Plastic Surgery Doctors in Miramar, FL Accepting Medicare

6 Plastic Surgery doctors found. Showing 1 - 6

Janet S. Mackenzie, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 3601 Sw 160th Ave, Suite 250, Miramar, FL 33027 Phone: 877-866-7123

Ina A Nevdakh, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 12741 Miramar Pkwy Ste 301, Miramar, FL 33027 Phone: 142-564-7846

Manohar P Rao, Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3601 Sw 160th Ave Ste 250, Miramar, FL 33027 Phone: 877-866-7123

Dr. John Howell Tiller, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 3601 Sw 160th Ave, Suite 250, Miramar, FL 33027 Phone: 877-866-7123    Fax: 855-855-2792

Dr. Vetra Anete Gipson, MD Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3601 Sw 160th Ave, Suite 250, Miramar, FL 33027 Phone: 305-866-9951    Fax: 877-284-8933

Dr. Jeffery Wayne Seitzinger, MD Plastic Surgery Medicare: Medicare Enrolled Practice Location: 3601 Sw 160th Ave, Suite 250, Miramar, FL 33027 Phone: 954-399-4642    Fax: 877-859-8768

News Archive

GTS, the first company to develop and commercialize a unique form of ultrasound technology

Guided Therapy Systems, LLC (GTS), a leading medical technology company, is the first company in the world to develop and commercialize products that employ a unique form of ultrasound technology, Intense Therapeutic Ultrasound (ITU).

Boston Scientific, Brainlab form strategic collaboration

Boston Scientific Corporation announces a collaboration with Brainlab AG, a leading software-driven medical technology company that helps improve patient treatment planning and surgical navigation.

Researchers are one step closer to understanding how blood cells develop through the use of human embryonic stem cells

This process is also significant because the blood cells were developed without the use of animal serum, which was previously thought to be essential for blood cell development. Instead, specific growth factors are added to guide the cell differentiation.

CHLA, House Research Institute receive FDA approval to begin pediatric ABI clinical trial

L.A.-based House Research Institute and Children's Hospital Los Angeles announced today that the United States Food and Drug Administration (FDA) has given final approval to begin a clinical trial of an Auditory Brainstem Implant (ABI) procedure for children.

Kolltan Pharmaceuticals signs license agreement with University of Toronto for novel anti-KIT antibodies

Kolltan Pharmaceuticals, a privately held biopharmaceutical company, today announced the Company has signed a license agreement with the University of Toronto for novel anti-KIT receptor tyrosine kinase antibodies identified in the laboratories of Dr. Sachdev Sidhu at the University of Toronto and the laboratory of Dr. Joseph Schlessinger of Yale University.

Read more Medical News

› Verified 6 days ago